Do physiologic stress and systemic illness shift thyroid hormone metabolism toward higher reverse T3 and lower active T3?

Physiologic stress and systemic illness trigger a well-characterized metabolic adaptation known as nonthyroidal illness syndrome (NTIS), often referred to as "sick euthyroid syndrome." This state is defined by a rapid decline in serum concentrations of the active hormone triiodothyronine (T3) and a corresponding increase in the inactive metabolite reverse T3 (rT3). These shifts are frequently observed in contexts ranging from major surgery and acute infection to severe psychological stress and chronic inflammatory conditions.

Clinical and effectiveness evidence

In clinical settings, the magnitude of the shift toward low T3 and high rT3 is often correlated with the severity of the illness.

• Active T3 reduction: Studies have shown that active T3 levels can drop by up to 50% within 24 to 48 hours of the onset of critical illness or major physiologic trauma.
• Reverse T3 elevation: Simultaneously, rT3 levels rise significantly. In patients with severe systemic disease, rT3 levels can double or triple, serving as a sensitive marker for the severity of the systemic insult.
• Cortisol and Cytokines: High levels of endogenous cortisol and pro-inflammatory cytokines, specifically Interleukin-6 (IL-6), Interleukin-1 (IL-1), and Tumor Necrosis Factor-alpha (TNF-α), are the primary drivers of these changes. In human cell models, IL-6 has been directly shown to block the peripheral conversion of T4 to T3.

Mechanistic explanations

The redistribution of thyroid hormones is driven by a coordinated change in the activity of deiodinase enzymes, which are responsible for the activation and inactivation of thyroid hormones at the cellular level.

• Inhibition of Activation (D1 and D2): Under normal conditions, Type 1 (D1) and Type 2 (D2) deiodinases catalyze the outer-ring deiodination of T4 into the biologically active T3. During systemic illness, inflammatory signaling and high cortisol inhibit these enzymes, particularly in the liver and kidneys, drastically reducing the systemic production of active T3.
• Induction of Inactivation (D3): Conversely, systemic stress induces the expression of Type 3 deiodinase (D3). This enzyme is the primary inactivator of thyroid hormone; it performs inner-ring deiodination, converting T4 into reverse T3 (rT3) and further degrading active T3 into T2.
• Molecular Signaling: The upregulation of D3 is mediated through pathways such as NF-κB and Shh/Gli1, which are activated by the immune response. This reciprocal change—downregulation of D1/D2 and upregulation of D3—creates a metabolic "shunt" that diverts T4 away from activation and toward inactivation.

Bottom line

Physiologic stress and illness reliably shift thyroid metabolism toward higher rT3 and lower active T3. This occurs through the specific inhibition of activating deiodinases (D1/D2) and the induction of the inactivating deiodinase (D3), a process largely mediated by inflammatory cytokines and cortisol.